Streamlined.financeStreamlined.finance
MarketsFind Stocks

Pfizer Inc.

NYSE

Market Cap.

151.41B

Avg. Volume

31.75M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Pfizer Inc.

Pfizer Inc. News

Pfizer Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - General
pfizer.com

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer Inc. Earnings & Revenue

Pfizer Inc. Financials

Table Compare

Compare PFE metrics with:

   

Earnings & Growth

PFE

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

PFE

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

PFE

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

PFE

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Pfizer Inc. Income

Pfizer Inc. Balance Sheet

Pfizer Inc. Cash Flow

Pfizer Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioNeutral
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Pfizer Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.6800

Payment DateDividendFrequency
2024-12-020.42Quarterly
2024-09-030.42Quarterly
2024-06-140.42Quarterly
2024-03-010.42Quarterly
2023-12-040.41Quarterly

Pfizer Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Pfizer Inc. Executives

NameRole
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development
Mr. Douglas M. LanklerExecutive Vice President & General Counsel
Mr. David M. DentonChief Financial Officer & Executive Vice President
Mr. Andreas J. PanayiotouGlobal Chief Marketing Officer
NameRoleGenderDate of BirthPay
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer19624.05M
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development19582.41M
Mr. Douglas M. LanklerExecutive Vice President & General CounselMale19661.76M
Mr. David M. DentonChief Financial Officer & Executive Vice PresidentMale19651.75M
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerMale

--

Pfizer Inc. Insider Trades

Date31 Oct
NameJOHNSON RADY A
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares7
Date31 Oct
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares19
Date30 Oct
NameGottlieb Scott
RoleDirector
TransactionAcquired
TypeP-Purchase
Shares1000
Date15 Oct
NameJOHNSON RADY A
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares6
Date15 Oct
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares18
DateNameRoleTransactionTypeShares
31 OctJOHNSON RADY AExecutive Vice PresidentAcquiredA-Award7
31 OctBOURLA ALBERTChairman & CEOAcquiredA-Award19
30 OctGottlieb ScottDirectorAcquiredP-Purchase1000
15 OctJOHNSON RADY AExecutive Vice PresidentAcquiredA-Award6
15 OctBOURLA ALBERTChairman & CEOAcquiredA-Award18

Discover More

Streamlined Academy

Pfizer Inc.

NYSE

Market Cap.

151.41B

Avg. Volume

31.75M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Pfizer Inc. News

Pfizer Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Pfizer Inc. Earnings & Revenue

Pfizer Inc. Income

Pfizer Inc. Balance Sheet

Pfizer Inc. Cash Flow

Pfizer Inc. Financials Over Time

Pfizer Inc. Executives

NameRole
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development
Mr. Douglas M. LanklerExecutive Vice President & General Counsel
Mr. David M. DentonChief Financial Officer & Executive Vice President
Mr. Andreas J. PanayiotouGlobal Chief Marketing Officer
NameRoleGenderDate of BirthPay
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & Chief Executive Officer19624.05M
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development19582.41M
Mr. Douglas M. LanklerExecutive Vice President & General CounselMale19661.76M
Mr. David M. DentonChief Financial Officer & Executive Vice PresidentMale19651.75M
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerMale

--

Pfizer Inc. Insider Trades

Date31 Oct
NameJOHNSON RADY A
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares7
Date31 Oct
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares19
Date30 Oct
NameGottlieb Scott
RoleDirector
TransactionAcquired
TypeP-Purchase
Shares1000
Date15 Oct
NameJOHNSON RADY A
RoleExecutive Vice President
TransactionAcquired
TypeA-Award
Shares6
Date15 Oct
NameBOURLA ALBERT
RoleChairman & CEO
TransactionAcquired
TypeA-Award
Shares18
DateNameRoleTransactionTypeShares
31 OctJOHNSON RADY AExecutive Vice PresidentAcquiredA-Award7
31 OctBOURLA ALBERTChairman & CEOAcquiredA-Award19
30 OctGottlieb ScottDirectorAcquiredP-Purchase1000
15 OctJOHNSON RADY AExecutive Vice PresidentAcquiredA-Award6
15 OctBOURLA ALBERTChairman & CEOAcquiredA-Award18

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - General
pfizer.com

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Pfizer Inc.

Pfizer Inc. Financials

Table Compare

Compare PFE metrics with:

   

Earnings & Growth

PFE

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

PFE

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

PFE

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

PFE

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Pfizer Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.6800

Payment DateDividendFrequency
2024-12-020.42Quarterly
2024-09-030.42Quarterly
2024-06-140.42Quarterly
2024-03-010.42Quarterly
2023-12-040.41Quarterly

Pfizer Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioNeutral
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)